Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis - Top-Institutions - MDSpire

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis

  • By

  • Ling Niu

  • Rong Ma

  • Cuijuan Miao

  • Fang Liu

  • Boyi Li

  • May 8, 2026

  • 0 min

Share

Top Institutions in Nephrology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic – Glickman Urological & Kidney Institute
    Cleveland Clinic – Glickman Urological & Kidney Institute

    Cleveland, Ohio

    Key Differentiators

    • Nephrology

  • #2

    Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital

    New York, New York

    Key Differentiators

    • Nephrology

  • #3

    Diabetes Prevention Program
    Diabetes Prevention Program

    N/A, N/A

    Key Differentiators

    • Diabetes
    • Nephrology

  • #4

    Swedish CArdioPulmonary BioImage Study
    Swedish CArdioPulmonary BioImage Study

    N/A, N/A

    Key Differentiators

    • Nephrology

  • #5

    KORA FF4
    KORA FF4

    N/A, N/A

    Key Differentiators

    • Nephrology

Original Source(s)

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis

  • by Ling Niu, Rong Ma, Cuijuan Miao, Fang Liu, Boyi Li

  • May 8, 2026

Related Content

From persistent hypercalcemia to parathyroid carcinoma: a case report of acute urinary retention and the diagnostic role of Ki-67

Gastroenterologically relevant high alert medications prescribed to children with chronic diseases—a consensus-driven single-center pilot study

Child Opportunity Index and Prevalence of Obesity and Hypertension in Adolescents with Congenital Heart Disease